Table 6: Comparison of median percentage changes in retinal diabetic macular edema between treatment group and placebo group.

Timeline

Median Percentage change in
retinal diabetic macular edema (%)

P-value

Treatment group

(n = 14)

Placebo group

(n = 12)

Median

IQR

Median

IQR

Baseline to Week 12

- 46.69

31.22

-35.60

64.47

0.133

Week 12 to Week 36

- 0.36

60.20

29.09

186.53

0.107

Baseline to Week 36

- 48.87

63.71

25.10

299.32

0.045*

Data is not normally distributed. Mann-whitney test. *Significant at p < 0.05; n: number of eyes; Week 12: at 12 weeks of treatment; Week 36: 24 weeks after treatment cessation.